Corthera
Corthera is engaged in acquiring, developing and commercializing therapies for illnesses in the acute care setting.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD185m (Public information from Dec 2009)
San Carlos California (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
$2.1m | Series A | ||
$15.0m | Series B | ||
$23.0m | Series C | ||
$120m Valuation: $120m | Acquisition | ||
| Total Funding | AUD62.0m | ||